retrospective study

  1. Nelson Vergel

    Retatrutide (GLP-3): Complete Guide to Dosing, Results, and Side Effects

    Curated By Nelson Vergel | ExcelMale.com | Updated March 2026 Key Takeaways Retatrutide is a first-in-class triple hormone receptor agonist (GLP-1 + GIP + glucagon) from Eli Lilly, currently in Phase 3 clinical trials under the TRIUMPH program. In Phase 3 (TRIUMPH-4), participants on the...
  2. J

    Low T ab Independent Risk Factor for Heart Disease

    From the abstract: Whether androgen deficiency among men increases the risk of cardiovascular (CV) events or is merely a disease marker remains a subject of intense scientific interest. In this post hoc analysis of men with available baseline plasma T concentrations, we examined the...
Back
Top